Corcept Therapeutics
CORT
CORT
59 hedge funds and large institutions have $161M invested in Corcept Therapeutics in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 4 closing their positions.
Holders
59
Holders Change
+10
Holders Change %
+20.41%
% of All Funds
1.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
24
Reduced
6
Closed
4
Calls
$2.64M
Puts
$233K
Net Calls
+$2.41M
Net Calls Change
+$2.36M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$6.48M |
| 2 |
ISL
2
Ingalls & Snyder LLC
New York
|
$28.3M |
| 3 |
3
Federated Hermes
Pittsburgh,
Pennsylvania
|
$53.3M |
| 4 |
TC
4
TFS Capital
West Chester,
Pennsylvania
|
$2.19M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$9.28M |
Top Sellers
| 1 |
1
First Eagle Investment Management
New York
|
$0 |
| 2 |
2
Northern Trust
Chicago,
Illinois
|
$2.86M |
| 3 |
TG
3
TCW Group
Los Angeles,
California
|
$162K |
| 4 |
4
D.E. Shaw & Co
New York
|
$0 |
| 5 |
5
Citigroup
New York
|
$38K |
